'Not buying it': Nearly half of Israelis say Israel and US did not win Iran war, poll finds

46% of respondents believe Israel and the U.S. did not win the war with Iran while only 22% view it as a victory; 63% of Israelis said they were dissatisfied with the war outcome versus 32% satisfied. Military leaders scored highest: Air Force Commander Tomer Bar 77% satisfaction and IDF Chief Eyal Zamir 71%; political figures lagged—Netanyahu 47% (92% coalition / 24% opposition) with 49% dissatisfied, Defense Minister Katz 40% satisfied (51% dissatisfied), and Finance and Education ministers at 29%. Poll of 500 adults by Lazar Research, margin of error ±4.3%.

Analysis

The public’s split perception of outcome and clear polarization raise the probability of sustained political volatility in Israel over the next 3–12 months, which typically translates into a higher risk premium on domestic assets. Mechanically, this manifests as wider sovereign and bank credit spreads (we model a plausible 20–60bp widening vs. comparable-duration peers if polarization persists into an election cycle) and larger FX swings in USD/ILS as capital allocators re-price policy risk.

High public confidence in military leadership combined with poor ratings for key economic ministers implies procurement and force-readiness programs are politically easier to prioritize than broader fiscal spending. That creates a second-order bias toward weapons, avionics, ISR and sustainment budgets being insulated or accelerated even as civilian infrastructure or social programs face cuts — a 12–24 month, lumpy revenue tailwind for niche defense OEMs and systems integrators that supply the Air Force and tactical ISR.

From a positioning perspective, broad Israeli beta is asymmetric: equity and sovereign exposures are vulnerable to headline-driven de-ratings while specialist defense names have convex upside tied to procurement cycles and US security assistance flows. Short-dated sentiment swings (days–weeks) will likely be dominated by political headlines; durable moves require budget votes or formal procurement announcements (the primary catalysts to watch over 3–12 months).

Key risks that could reverse the trade are a rapid diplomatic détente, a sizable US security package that neutralizes local political arguments, or domestic budget constraints delaying orders — any of which could compress spreads and re-rate broad Israeli assets higher within weeks. Conversely, an extended election campaign or major domestic unrest could push the downside scenario (market widening, shekel weakness, hit to non-defense capex) and crystallize gains for defense-specialist suppliers over 6–18 months.

Key Decisions for Investors

• Long ESLT (Elbit Systems) — buy shares or 12–24 month LEAP calls to capture a targeted 25–40% upside if Israeli air/avionics and ISR procurement accelerates; risk: program delays or FX headwinds could cause a 15–25% drawdown. Use a 20% stop or hedge with a modest short EIS position.
• Pair trade — long ESLT / short EIS (iShares MSCI Israel ETF) for 3–9 months: asymmetric payoff capturing defense-specific upside while hedging broad domestic risk. Target: net positive if ESLT +20% and EIS -10%; cap loss to ~10% if market-wide risk-on re-rates Israeli equities.
• Buy 9–15 month call spreads on LMT or RTX (defense primes) to gain exposure to accelerated air-defense and missile demand with defined downside (debit) and 2–4x upside if orders or US aid accelerate. Use near-ATM call spreads to limit theta bleed and size as a satellite position (2–5% portfolio).
• FX hedge/position — buy USD/ILS forwards or call options (3–6 month tenor) to protect/benefit from potential shekel weakening tied to prolonged political uncertainty. Target a 3–6% move; cap option premium to <0.5% of portfolio value as insurance cost.